Related Experiment Videos
Human eosinophil granule major basic protein and its novel homolog
D A Plager1, S Stuart, G J Gleich
1Department of Immunology, Mayo Clinic and Foundation, Rochester, MN 55905, USA.
Abstract:
Human MBP is associated with an array of in vitro cytotoxic and cytostimulatory activities, mediated in part by its strong basicity. It is most prominently found in the eosinophil, but is also present in placental X cells and placental-site giant cells during pregnancy. Pathologically, its pattern of tissue deposition and its ability to induce characteristic pathophysiologic changes, such as bronchial hyperreactivity and vasopermeability, strongly suggest a role for MBP in allergic and eosinophilic diseases. The role of MBP in protection from helminthic disease is also evident. Here, we present information on a novel homolog of eosinophil granule MBP with biologic activities similar to that of MBP. However, results from experiments on eosinophil granules suggest that the quantity of the homolog present in the eosinophil granule is significantly less than that of MBP itself. Further, preliminary experiments indicate that the two proteins are not synergistic in terms of their cytotoxic and cytostimulatory biologic activities. Future experiments must determine whether the MBP homolog is deposited at sites of tissue damage and can be detected in biologic fluids at concentrations required for biologic activity.
Insights
A novel homolog of human eosinophil major basic protein (MBP) exhibits similar biologic activities. However, this homolog is present in lower quantities and does not synergize with MBP, suggesting distinct roles in disease.
Area of Science:
- Immunology
- Cell Biology
- Allergy and Asthma Research
Background:
- Human eosinophil major basic protein (MBP) possesses significant in vitro cytotoxic and cytostimulatory activities, largely due to its basicity.
- MBP is primarily found in eosinophils but also present in placental cells during pregnancy.
- Pathological roles of MBP are implicated in allergic diseases, eosinophilic disorders, and helminthic infections.
Purpose of the Study:
- To investigate a newly identified homolog of eosinophil MBP.
- To compare the biologic activities and characteristics of the MBP homolog with native MBP.
Main Methods:
- Biochemical analysis of eosinophil granules.
- In vitro assessment of cytotoxic and cytostimulatory activities.
- Comparative studies of MBP and its novel homolog.
Main Results:
- A novel MBP homolog was identified with biologic activities comparable to MBP.
- The MBP homolog is present in significantly lower concentrations within eosinophil granules compared to MBP.
- Preliminary data indicate no synergistic activity between MBP and its homolog in cytotoxic or cytostimulatory functions.
Conclusions:
- The MBP homolog may have distinct biological functions separate from MBP.
- Further research is required to determine the in vivo deposition and functional concentrations of the MBP homolog at sites of tissue damage.
- Understanding the role of this homolog is crucial for a comprehensive view of eosinophil-mediated inflammatory and protective responses.